VGX Pharmaceuticals Co-Founder Professor David B. Weiner To Chair The First DNA Vaccines Conference In Asia

Main Category: Immune System / Vaccines
Also Included In: Conferences
Article Date: 03 Mar 2008 - 8:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

VGX Pharmaceuticals Inc. (VGX) announced that Professor David B. Weiner of the University of Pennsylvania will serve as the Chairman of the DNA Vaccines Asia 2008 Conference next week in Seoul, Korea. Professor Weiner is a pioneer in the field of DNA vaccines and a VGX co-founder.

The conference-the first of such meetings in Asia-will bring together the pioneering scientists and thought leaders of DNA vaccines and therapies in Asia and the US. The conference will be held on March 4th and has an agenda covering a broad range of topics including current DNA vaccine research, product development and manufacturing. In addition to Professor Weiner, the conference speakers include Professor Shan Lu of University of Massachusetts, Professor Bin Wang of China Agriculture University, Professor Chang-yuil Kang of Seoul National University, Professor Eiji Kobayashi of Jichi Medical School, and Dr. Ruxandra Draghia-Akli of VGX Pharmaceuticals and other distinguished experts in the field of DNA vaccines and therapies. The delegates at the conference represent professionals from biotechnology companies, major pharmaceutical companies, academic institutions, and government labs throughout Asia. The conference is sponsored by VGX and Biologics Resources, Inc.

VGX Pharmaceuticals Inc.